About
Eric Pasmant is a Statutory researcher specializing in the genomics and epigenetics of rare tumors at a Paris-based research institute, operating within the French national scientific ecosystem. His work focuses on unraveling genetic and epigenetic mechanisms underlying uncommon cancer types to identify novel diagnostic markers and therapeutic targets.
His research spans critical domains in oncological science:
- Cancer Research with emphasis on rare and understudied tumor pathologies
- Genomics including DNA sequencing and structural variation analysis
- Epigenetics investigating non-sequence-based heritable gene expression changes
- Rare Tumors molecular pathogenesis and classification
- Molecular Biology providing fundamental experimental methodologies
No scientific awards, student mentorship details, or grant information was provided in the source material, though his statutory position indicates permanent research status within France's institutional framework.
0Publications listed
